alexa
 
Home News Dishman Pharma zooms 20% as merger with arms becomes effective

Read more interesting news from around the globe with Wealth Doctor App

Google Play
 
Dishman Pharma zooms 20% as merger with arms becomes effective

Dishman Pharma zooms 20% as merger with arms becomes effective

Tuesday, March 28, 2017, 10:21 AM

Shares of Dishman Pharmaceuticals shot up 20% in Tuesday’s trade after the drugmaker informed exchanges that its amalgamation with Carbogen Amcis (India) (CAIL) and Dishman Care (DCL) has become effective from March 17. But what probably led the stock rally reported that the USFDA approves Tesaro Inc's Ovarian Cancer drug Zejula. Analysts believe Dishman Pharma could be a major beneficiary.
Read More

Learn to Save, Spend, Invest & Borrow Wisely with our Youtube Channel

Get It now!